TSHA
Taysha Gene Therapies, Inc.Healthcare$4.57
▲ Bullish
Mkt Cap: $1.31BFloat: 198.3MSI: 23.4%DTC: 17.8
Data as of market close Apr 7, 2026
IV Rank
-
IV Pctl
-
HV 20d
74.1%
52W Range
$1-$6
ATR(14)
$0.27
Exp. Move
±13.7%
P/C Ratio
0.14
Earnings
May 14
GEX Positive
DEX Long
Net Call Premium
Max Pain Below
Exp. Move Wide
Low Put/Call
TSHA Key Options Data
- Total GEX
- $0.00B
- Total DEX
- $0.2M
- Max Pain
- $4.00
- Expected Move
- ±13.7%
- Put/Call OI
- 0.14
- Net Premium
- $0.0M
- Spot Price
- $4.57
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 10 | ±$0.62 | ±13.7% | $3.95 | $5.20 |
| 2026-05-15 | 38 | ±$0.50 | ±10.9% | $4.07 | $5.07 |
| 2026-06-18 | 72 | ±$0.53 | ±11.5% | $4.05 | $5.10 |
| 2026-07-17 | 101 | ±$1.83 | ±39.9% | $2.75 | $6.40 |
| 2026-12-18 | 255 | ±$3.75 | ±82.1% | $0.82 | $8.32 |
Explore TSHA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.